Significance of Carbohydrate Antigen 19-9 as a biomarker in Hepatocellular Carcinoma and Cholangiocarcinoma

Q3 Medicine

Open Biomarkers Journal Pub Date : 2021-05-17 DOI:10.2174/1875318302111010039

Badawy A. Abdulaziz, W. Agawy, M. Ibrahim, M. Khalil, W. A. Halim

引用次数: 0

Abstract

Background & Aims: Combined hepatocellular cholangiocarcinomas (cHCC-CCs) are rare malignancies representing less than 1% of all primary liver cancers. Correct preoperative diagnosis is desirable because the frequency of lymph node metastasis in ICC and cHCC-CC, making lymph node dissection a necessity if curative resection to be attempted. This study aimed to investigate the significance of elevated CA19-9 in suspecting a diagnosis of Intrahepatic Cholangiocarcinoma (ICC) “non-invasively” in patients with typical radiological features of HCC.

查看原文本刊更多论文

糖类抗原19-9在肝细胞癌和胆管癌中的意义

背景与目的:合并肝细胞胆管癌(cHCC-CCs)是一种罕见的恶性肿瘤，占所有原发性肝癌的不到1%。正确的术前诊断是必要的，因为在ICC和cHCC-CC中淋巴结转移的频率，使得淋巴结清扫是必要的，如果试图根治性切除。本研究旨在探讨CA19-9升高在HCC典型影像学特征患者“无创”怀疑肝内胆管癌(ICC)诊断中的意义。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Open Biomarkers Journal Medicine-Medicine (miscellaneous)

CiteScore

0.80

自引率

0.00%

发文量

期刊介绍： The Open Biomarkers Journal is an Open Access online journal, which publishes original full-length, short research articles and reviews on biomarkers in clinical, medical and pharmaceutical research. The coverage includes biomarkers of disease, new biomarkers, exposure to drugs, genetic effects, and applications of biomarkers. The Open Biomarkers Journal, a peer reviewed journal, aims to provide the most complete and reliable source of information on current developments in the field. The emphasis will be on publishing quality articles rapidly and freely available to researchers worldwide.